Tacrolimus effect on rosacea
- PMID: 14699377
- DOI: 10.1016/s0190-9622(03)02157-1
Tacrolimus effect on rosacea
Abstract
Twenty-four patients with erythrotelangiectatic or papulopustular rosacea were treated with 0.1% tacrolimus topical ointment in a 12-week open-label trial. Erythema was significantly improved in both rosacea subtypes (P<.05). There was no decrease in the number of papulopustular lesions. Side effects were consistent with those on the tacrolimus topical ointment labeling.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical